Skip to main content
Clinical Trials/CTRI/2023/02/049838
CTRI/2023/02/049838
Not yet recruiting
Phase 3

A Randomized, single blind , Multicentre, Clinical study to Evaluate Effectiveness of Rotatory handle toothbrush compared to conventional handle [straight &Flexible toothbrush]

Dr.Gowri Pendyala0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr.Gowri Pendyala
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr.Gowri Pendyala

Eligibility Criteria

Inclusion Criteria

  • Participants/dental laypeople (i.e. people without any dental background) having at least 20 natural, scorable teeth with a visible plaque accumulation represented by a continuous band of plaque (up to 1 mm) at the cervical margin on at least 30% of all facial tooth surfaces as measured by the Turesky Modification of the Quigley\-Hein Plaque Index (TMQHPI) (score greater than 2 in this index),ready to give written informed consent, residing at catchment area of study setting and seeking treatment of teeth scaling (cleaning) in Department of Periodontology

Exclusion Criteria

  • The participants who had undergone any surgery, chemical, antibiotic/dental prophylaxis on the experimental area within the 3 months prior to the study ,Subjects showing major tissue lesions and those presenting orthodontic banding or intraoral prosthesis, Pregnant, subjects with irregular brushing frequency less than 2 time/day), without complete dentition, carious teeth, Bidi or Cigarettes smokers, oral tobacco or gutkha user ,Probing depth greater than 3 mm on the facial and lingual\-palatal surfaces and any physical impairment that affects oral hygiene

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
A Randomized, Single-blind, Multi-center Clinical Study for Artemisinin-Piperazine and Artemether-Benzolol in the Treatment of Uncomplicated Falciparum MalariaMalaria
ITMCTR1900002588Guangzhou University of Chinese Medicine
Active, not recruiting
Phase 1
A randomized study in hospitalised patients with complicated urinary tract infections caused by Gram-negative bacteria to compare the efficacy and safety of S-649266 to Imipenem/Cilastin, both administered by intravenous infusio
EUCTR2014-000914-76-LVShionogi Inc.400
Active, not recruiting
Phase 1
A randomized study in hospitalised patients with complicated urinary tract infections caused by Gram-negative bacteria to compare the efficacy and safety of S-649266 to Imipenem/Cilastin, both administered by intravenous infusioComplicated Urinary Tract Infections with or without Pyelonephritis or Acute Uncomplicated Pyelonephritis caused by Gram-negative PathogensMedDRA version: 19.0Level: HLTClassification code 10046577Term: Urinary tract infectionsSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2014-000914-76-CZShionogi Inc.450
Active, not recruiting
Phase 1
A randomized study in hospitalised patients with complicated urinary tract infections caused by Gram-negative bacteria to compare the efficacy and safety of S-649266 to Imipenem/Cilastin, both administered by intravenous infusioComplicated Urinary Tract Infections with or without Pyelonephritis or Acute Uncomplicated Pyelonephritis caused by Gram-negative PathogensMedDRA version: 19.0Level: HLTClassification code 10046577Term: Urinary tract infectionsSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2014-000914-76-DEShionogi Inc.450
Active, not recruiting
Phase 1
A randomized study in hospitalised patients with complicated urinary tract infections caused by Gram-negative bacteria to compare the efficacy and safety of S-649266 to Imipenem/Cilastin, both administered by intravenous infusio
EUCTR2014-000914-76-HUShionogi Inc.450